Why Vivos Therapeutics (VVOS) Stock Is Down 25% on Thursday
Why Vivos Therapeutics (VVOS) Stock Is Down 25% on Thursday
Vivos Therapeutics Inc (NASDAQ:VVOS) shares are trading lower by 26.1% to $3.05 during Thursday's session after the company announced a $4.3 million registered offering of 1.36 million shares of common stock at $3.15 per share.
在周四的交易中，Vivos Therapeutics Inc (纳斯达克: VVOS) 的股价下跌26.1%，至3.05美元，接近于公司宣布以每股3.15美元的价格发行了430万美元的注册股票发行项目后。
The direct offering is expected to close on September 20, pending standard closing conditions, and will generate approximately $4.3 million in gross proceeds. H.C. Wainwright & Co. is the exclusive placement agent for the offering.
预计该直接发行将于9月20日结束，待满足标准的交割条件，并将获得约430万美元的总收入。H.C. Wainwright资本融资公司是该发行项目的唯一放置经纪人。
Vivos says the company plans to use the net proceeds for working capital and general corporate purposes. Additionally, no stock purchase warrants are included in the offering.
Vivos表示公司计划将净收益用于 营运资本 和一般的企业目的。此外，本次发行不包括股票认购权证。
Read Also: Bank Stocks Hit Inflection Point After Fed's 50 Basis Point Cut, Analyst Reveals Top Picks
了解更多信息：美联储降息50个基点后，银行股发生拐点，分析师揭示了一些热门选择。
Is VVOS A Good Stock To Buy?
VVOS是一个值得购买的好股票吗？
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages – like Vivos Therapeutics's page for example – there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
投资者在决定是否购买某只股票时可以做出一些决策。除了在Benzinga的报价页面上找到的估值指标和价格走势以外（例如Vivos Therapeutics的页面），还有一些因素，例如一家公司是否支付股息或每个季度购买其大部分股票。
These are known as capital allocation programs. Vivos Therapeutics does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's dividend calendar for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
这些被称为资本配置计划。Vivos Therapeutics不支付股息，但显然公司有几种方式可以为股东提供回报。请随时搜索Benzinga的股息日历，查找下一个即将支付股息的公司，并确定持有公司股份可以获得何种收益率。
For example, if you're looking to earn an annualized return of 23.1%, you'll need to buy a share of North American Finl 15 by the Sep. 30, 2024. Once done, you can expect to receive a nominal payout of $0.11 on Oct. 10, 2024.
例如，如果您希望获得年化回报率为23.1%，您需要在2024年9月30日之前购买一股North American Finl 15。购买完成后，您可以预计在2024年10月10日收到0.11美元的名义支付。
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on Vivos Therapeutics will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
回购计划显然不同且变量很大。 一家公司可以批准回购计划，并根据其认为适当的时间购买股份，在授权的时间段内。通过查看最新的vivos therapeutics资讯，通常可以得知该公司最近是否批准了回购计划。回购计划通常用作支撑股价，充当需求的保障。
According to data from Benzinga Pro, VVOS has a 52-week high of $48.79 and a 52-week low of $1.91.
根据Benzinga Pro的数据，VVOS的52周最高价为48.79美元，52周最低价为1.91美元。
